Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
Vitamin A decreased the urinary excretion of total mucopolysaccharides in a patient with Hurler-Scheie compound (type IH-S mucopolysaccharidosis). Vitamin A was administered orally in daily doses of 1,000 to 2,000 IU/kg body weight for 10 years. Adverse clinical responses such as irritability, bone pain, dizziness, vomiting and diarrhea appeared in the patient and were controlled by reduction of the dose administered. No clinical improvement was observed, although it is possible that the clinical course of the disease may have been retarded.
D000293:Adolescent; D002809:Chondroitin Sulfates / Q000652:urine; D003871:Dermatan Sulfate / Q000652:urine; D004305:Dose-Response Relationship, Drug; D005260:Female; D006025:Glycosaminoglycans / Q000652:urine*; D006497:Heparan Sulfate / Q000652:urine; D006801:Humans; D008059:Mucopolysaccharidosis I / Q000188:drug therapy*; D013577:Syndrome; D014801:Vitamin A / Q000008:administration & dosage / Q000627:therapeutic use*
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D014801:Vitamin A